Finished dosage forms & personalised medicines
In this issue, we present a Panel Discussion on Finished dosage forms and personalised medicines. Experts from CROs & CDMOs have been invited to participate around a virtual table and discuss about solid oral dosage formulations, the emergence of biologic drugs, emerging technologies that can improve solubility, parenteral dosage forms and packaging innovation, continuous manufacturing and personalised medicines, regulatory framework, alternative drug delivery devices.
The following players have joined the initiative:
Don't have an account?